Back | Next |
home / stock / bcrx / bcrx message board
Subject | By | Source | When |
---|---|---|---|
The sharp increase in revenue is what got | Cosa | investorshub | 10/01/2021 8:02:19 PM |
Facepalm I jinxed you guys. | Cosa | investorshub | 10/01/2021 8:00:36 PM |
Hi Cosa, welcome | bhulkupk | investorshub | 09/29/2021 7:44:32 PM |
Hi, been in since March/april 2020 from $3s. | Deano361 | investorshub | 09/29/2021 7:44:21 PM |
Hello All, new here. Grabbed a little just | Cosa | investorshub | 09/29/2021 7:41:05 PM |
whytestocks: $BCRX News Article - BioCryst Announces Approval of ORLADEYO (berotralstat) in United A | whytestocks | investorshangout | 09/09/2021 6:20:58 PM |
Cant believe with all the recent news especially | easyrider1 | investorshub | 09/02/2021 1:02:06 AM |
Well, its one of my few long 3 | Deano361 | investorshub | 09/02/2021 12:31:30 AM |
Oh okay, so I can buy some for | bhulkupk | investorshub | 09/01/2021 11:43:52 PM |
Its a quote from executive and its all | Deano361 | investorshub | 09/01/2021 1:34:34 PM |
How? | bhulkupk | investorshub | 09/01/2021 1:22:14 PM |
Embarrassment of riches! | Limey42 | investorshub | 09/01/2021 11:19:11 AM |
I think it is a public show of | MZlu | investorshub | 08/11/2021 5:06:36 AM |
Totally agree. No one saw secondary offering | easyrider1 | investorshub | 08/11/2021 3:09:48 AM |
Some crazy shit Stoney pulled off today!!! | Limey42 | investorshub | 08/11/2021 1:59:59 AM |
Today showed power of shortsdropping share price to | easyrider1 | investorshub | 08/06/2021 2:01:08 AM |
I believe $30 per share and likely a | easyrider1 | investorshub | 08/06/2021 1:32:03 AM |
Well into triple digits in 2022-2024 | ttubular | investorshub | 08/05/2021 1:18:33 PM |
This a solid play? Price predictions here for | amonoy1992 | investorshub | 08/05/2021 11:58:26 AM |
The daily dips under $17, set us up | easyrider1 | investorshub | 07/30/2021 11:14:58 AM |
News, Short Squeeze, Breakout and More Instantly...
BioCryst Pharmaceuticals Inc. Company Name:
BCRX Stock Symbol:
NASDAQ Market:
BioCryst Pharmaceuticals Inc. Website:
RESEARCH TRIANGLE PARK, N.C., July 22, 2024 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company will report its second quarter 2024 financial results on Monday, August 5, 2024. BioCryst management will host a conference call and webcast ...
RESEARCH TRIANGLE PARK, N.C., July 09, 2024 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the General Directorate of Medicines, Supplies and Drugs (DIGEMID) in Peru has granted approval for oral, once-daily ORLADEYO ® (berotralstat) for t...
2024-06-27 04:12:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...